Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/BBF9DA41.svg?ark=w1%2F20260522%2FBBF9DA41&value=id)](https://nobleid.org/work/w1/20260522/BBF9DA41)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors